David V. Herin

585 total citations
14 papers, 461 citations indexed

About

David V. Herin is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, David V. Herin has authored 14 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cellular and Molecular Neuroscience, 6 papers in Psychiatry and Mental health and 4 papers in Pharmacology. Recurrent topics in David V. Herin's work include Neurotransmitter Receptor Influence on Behavior (9 papers), Attention Deficit Hyperactivity Disorder (5 papers) and Substance Abuse Treatment and Outcomes (4 papers). David V. Herin is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (9 papers), Attention Deficit Hyperactivity Disorder (5 papers) and Substance Abuse Treatment and Outcomes (4 papers). David V. Herin collaborates with scholars based in United States, Colombia and Bulgaria. David V. Herin's co-authors include John Grabowski, Joy M. Schmitz, Craig R. Rush, Marc Mooney, Charles E. Green, Kathryn A. Cunningham, Angela L. Stotts, F. Gerard Moeller, Jan A. Lindsay and Luis Orozco‐Cabal and has published in prestigious journals such as Annals of the New York Academy of Sciences, Psychopharmacology and Drug and Alcohol Dependence.

In The Last Decade

David V. Herin

14 papers receiving 444 citations

Peers

Countries citing papers authored by David V. Herin

Since Specialization

Citations

This map shows the geographic impact of David V. Herin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David V. Herin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David V. Herin more than expected).

Fields of papers citing papers by David V. Herin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David V. Herin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David V. Herin. The network helps show where David V. Herin may publish in the future.

Co-authorship network of co-authors of David V. Herin

This figure shows the co-authorship network connecting the top 25 collaborators of David V. Herin. A scholar is included among the top collaborators of David V. Herin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David V. Herin. David V. Herin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Pilot study of the effects of lisdexamfetamine on cocaine use: A randomized, double-blind, placebo-controlled trial 2015 ·Drug and Alcohol Dependence ·Marc Mooney, David V. Herin, Sheila Specker, David Babb, Frances R. Levin, John Grabowski	35
2	Elevated Expression of Serotonin 5-HT2A Receptors in the Rat Ventral Tegmental Area Enhances Vulnerability to the Behavioral Effects of Cocaine 2013 ·Frontiers in Psychiatry ·David V. Herin, Marcy J. Bubar, Patricia K. Seitz, Mary L. Thomas, Gilbert R. Hillman, (unknown), Ping Wu, Kathryn A. Cunningham	14
3	Agonist‐like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies 2010 ·Annals of the New York Academy of Sciences ·David V. Herin, Craig R. Rush, John Grabowski	86
4	Validity and Reliability of the Abbreviated Barratt Impulsiveness Scale in Spanish (BIS-15S)* 2010 ·Revista Colombiana de Psiquiatría ·Luis Orozco‐Cabal, (unknown), David V. Herin, (unknown), José Miguel Uribe-Restrepo	51
5	High-Dose Naltrexone Therapy for Cocaine-Alcohol Dependence 2009 ·American Journal on Addictions ·Joy M. Schmitz, Jan A. Lindsay, Charles E. Green, David V. Herin, Angela L. Stotts, F. Gerard Moeller	36
6	Cocaine Dependence and Concurrent Marijuana Use: A Comparison of Clinical Characteristics 2009 ·The American Journal of Drug and Alcohol Abuse ·Jan A. Lindsay, Angela L. Stotts, Charles E. Green, David V. Herin, Joy M. Schmitz	31
7	Novel approach to data analysis in cocaine-conditioned place preference 2009 ·Behavioural Pharmacology ·(unknown), David V. Herin, James J. Grady, Kathryn A. Cunningham	14
8	High-Dose Naltrexone Therapy for Cocaine-Alcohol Dependence 2009 ·American Journal on Addictions ·Joy M. Schmitz, Jan M. Lindsay, Charles Green, David V. Herin, Angela L. Stotts, F. Gerard Moeller	6
9	Use of stimulants to treat cocaine and methamphetamine abuse 2008 ·Current Psychiatry Reports ·F. Gerard Moeller, Joy M. Schmitz, David V. Herin, Kimberly L. Kjome	18
10	Effects of oral methamphetamine on cocaine use: A randomized, double-blind, placebo-controlled trial 2008 ·Drug and Alcohol Dependence ·Marc Mooney, David V. Herin, Joy M. Schmitz, (unknown), Charles E. Green, John Grabowski	96
11	2008 ·PubMed ·Luis Orozco‐Cabal, David V. Herin	1
12	Obsessive-Compulsive Disorder Symptoms in Huntington's Disease: A Case Report. 2008 ·PubMed ·(unknown), (unknown), (unknown), (unknown), Santiago Tovar-Perdomo, David V. Herin, Luis Orozco‐Cabal	8
13	Chronic treatment with a serotonin2 receptor (5-HT2R) agonist modulates the behavioral and cellular response to (+)-3,4-methylenedioxymethamphetamine [(+)-MDMA] 2005 ·Drug and Alcohol Dependence ·(unknown), David V. Herin, Paul S. Frankel, Mary Thomas, Kathryn A. Cunningham	9
14	Role of the serotonin 5-HT2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine 2004 ·Psychopharmacology ·David V. Herin, Shijing Liu, Thomas Ullrich, Kenner C. Rice, Kathryn A. Cunningham	56

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact